IL‐1β and IL‐17A are involved in IVIG resistance through activation of C/EBPβ and δ in a coronary artery model of Kawasaki disease

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Allergy (Copenhagen) 2020-08, Vol.75 (8), p.2102-n/a
Hauptverfasser:	Inoue, Takashi, Miyashita, Masaki, Murakami, Shokei, Igarashi, Arisa, Motomura, Kenichiro, Abe, Jun, Matsumoto, Kenji, Matsuda, Akio
Format:	Artikel
Sprache:	eng
Schlagworte:	C/EBP CCAAT-Enhancer-Binding Protein-beta Coronary artery Coronary Artery Disease Coronary Vessels - diagnostic imaging Humans IL‐17A IL‐1β Immunoglobulins Immunoglobulins, Intravenous - therapeutic use Interleukin-17 Interleukin-1beta Intravenous administration IVIG Kawasaki disease Mucocutaneous lymph node syndrome Mucocutaneous Lymph Node Syndrome - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!